Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

unknown120%
active_not_recruiting120%
completed360%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Peer Approaches to Lupus Self-management

NCT03734055
completednot_applicable

Wellness Intervention for Menstrual Mood Disorders

NCT01995916
unknownnot_applicable

Family Psychoeducation for Major Depressive Disorder

NCT02348827
completednot_applicable

Mindfulness-based Psychotherapy for Drug-resistant Epilepsy

NCT02060422
completedphase_2

Support, Health, and Fibromyalgia

NCT00000423

Clinical Trials (5)

Showing 5 of 5 trials
NCT03734055Not Applicable

Peer Approaches to Lupus Self-management

Active Not Recruiting
NCT01995916Not Applicable

Wellness Intervention for Menstrual Mood Disorders

Completed
NCT02348827Not Applicable

Family Psychoeducation for Major Depressive Disorder

Unknown
NCT02060422Not Applicable

Mindfulness-based Psychotherapy for Drug-resistant Epilepsy

Completed
NCT00000423Phase 2

Support, Health, and Fibromyalgia

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5